Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Stratification in End Stage Renal Disease (ISAR)

NCT01152892 is registered in ClinicalTrials.gov with Technical University of Munich as lead sponsor.

NCT NCT01152892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01152892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Stratification in End Stage Renal Disease (ISAR)
Lead sponsor
Technical University of Munich
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2010
Completion date
May 31, 2020
Enrollment
500 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular event, chronic kidney disease, end stage renal disease, sudden cardiac death